Trials / Completed
CompletedNCT03785366
A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)
A Randomized, Single-Blind, Comparative Bioavailability Study to Assess the Pharmacokinetic Properties of VeraCept® Intrauterine Contraceptive vs ParaGard® in Healthy, Post-Menarcheal Women
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Sebela Women's Health Inc. · Industry
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
to Assess the Pharmacokinetic Properties of VeraCept® Intrauterine Contraceptive vs ParaGard® in Healthy, Post- Menarcheal Women
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VeraCept | VeraCept Intrauterine Device (IUD) |
| DRUG | ParaGard | ParaGard intrauterine copper contraceptive |
Timeline
- Start date
- 2018-12-17
- Primary completion
- 2019-12-30
- Completion
- 2024-08-01
- First posted
- 2018-12-24
- Last updated
- 2025-08-15
- Results posted
- 2025-08-15
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03785366. Inclusion in this directory is not an endorsement.